Journal: Biomolecules
Article Title: Targeting Integrin α2 to Overcome Imatinib Resistance in Chronic Myeloid Leukemia Cells
doi: 10.3390/biom15091245
Figure Lengend Snippet: Cells were treated with increasing concentrations of E7820 (0.06, 0.125, 0.25, 0.5, 1, 2.5, 5, 7.5, 10, 15, 20, and 23 μM), and cell viability was assessed. ( A ) K562S, ( B ) K562R-ima, and ( C ) K562R+ima cells were treated with E7820 and compared to untreated controls. ( n = 4) (* p < 0.05, *** p < 0.001, **** p < 0.0001).
Article Snippet: Later, the 5 μM resistant K562R cell line was produced by gradually increasing the IMA (Santa Cruz, Dallas, TX, USA) concentration over a period of 18 months using the K562R 0.6 cells as the starting population [ ].
Techniques: